Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Go back to Resources

Validation of a Genomic Classifier That Predicts Metastatic Disease Rogression in Men with Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High-Risk Pathologic Features Postprostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Go back to Resources

Validation of A Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an at Risk Patient Population

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Two Dimensional Echo Methods for Right Atrial Volume Assesment: Accuracy and Performance Using MRI as Reference

Go back to Resources

Two Dimensional Echo Methods for Right Atrial Volume Assesment: Accuracy and Performance Using MRI as Reference

Authors:

Secondary:

Location:

URL:

Go back to Resources

Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)

Go back to Resources

Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): the Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

Go back to Resources

Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Potential of the Poincare Plot in the Search for Meaningful Measures of Heart Rate Variability

Go back to Resources

The Potential of the Poincare Plot in the Search for Meaningful Measures of Heart Rate Variability

Authors:

Secondary:

Location:

URL:

Go back to Resources

The Potential of the Poincare Plot in the Search for Meaningful Measures of Heart Rate

Go back to Resources

The Potential of the Poincare Plot in the Search for Meaningful Measures of Heart Rate

Authors:

Secondary:

Location:

URL:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Current page 213
  • Page 214
  • Page 215
  • Page 216
  • Page 217
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification